Por: RTTNews Health February 02, 2023
Biotechnology company INOVIO Pharmaceuticals, Inc. () announced Thursday positive results from a Phase 1b clinical trial evaluating INO-4201, a DNA vaccine candidate, as a booster in healthy adult participants who previously received a single injection of Ervebo.In the trial, INO-4201 was well-tolerated and boosted humoral responses in 100% (36 of 36) of treated participants.INO-4201 was evaluated in a 46-participant randomized,... + full article
ABC News USA Life February 04, 2023
Two types of artificial tears eye drops have been voluntarily recalled following 55 reports of adverse use effects, including eye infections, vision loss and even a bloodstream infection that led to one death, according to federal officials.The affected eye drops were... + más
Eye drops recalled after 55 reports of bacterial infection, 1 death in 12 states | ABC7
EzriCare recalls artificial tear drops after reports of vision loss and 1 death | CBS News
Forbes USA Tech November 11, 2022
, Chief Experience Officer, THREAD Research. getty The Elephant In The Drug Development Room Clinical trials are the FDA-mandated process by which pharmaceutical companies confirm that the efficacy and safety of their new drugs make them worthy of government approval, then... + más
Fintech Company Greenphire Wants To Make Clinical Trials More Representative Of Every Person, From All Backgrounds And Abilities | Forbes
Council Post: 'Stayin' Alive': Patient Centricity In Decentralized Clinical Trials | Forbes
RTTNews USA Health October 13, 2022
Biotechnology company Inovio Pharmaceuticals Inc. () announced Thursday positive interim results from an ongoing Phase 1/2 clinical trial evaluating INO-3107 for the treatment of HPV 6 and HPV 11-associated Recurrent Respiratory Papillomatosis (RRP) in adults.In the first cohort... + más
Surge of respiratory illnesses in children straining some hospitals' capacity | ABC News
NKorea launches 2 missiles toward sea after US-SKorea drills | ABC News
WPLG Local 10 USA Nation October 09, 2022
SEOUL – North Korea fired two short-range ballistic missiles toward its eastern waters on Sunday, the latest of a recent barrage of weapons tests, a day after it warned the redeployment of near the Korean Peninsula was inflaming regional tensions.South Korea’s Joint Chiefs... + más
NKorea launches 2 missiles toward sea after US-SKorea drills | ABC7
ABC7 USA World October 09, 2022
SEOUL, South Korea -- North Korea fired two short-range ballistic missiles toward its eastern waters on Sunday, the latest of a recent barrage of weapons tests, a day after it warned the redeployment of a U.S. aircraft carrier near the Korean Peninsula was inflaming regional... + más
NKorea launches 2 missiles toward sea after US-SKorea drills | WPLG Local 10
10 WBNS USA Nation October 08, 2022
SEOUL, South Korea — North Korea fired two short-range ballistic missiles toward its eastern waters on Sunday, the latest of its recent barrage of weapons tests, a day after the North warned the redeployment of near the Korean Peninsula was inflaming regional tensions. South... + más
North Korea fires 4th round of missile tests in 1 week | ABC News
North Korea fires 4th round of missile tests in 1 week | Portland Press Herald
ABC News USA World October 08, 2022
SEOUL, South Korea -- North Korea fired two short-range ballistic missiles toward its eastern waters on Sunday, the latest of its recent barrage of weapons tests, a day after the North warned that the redeployment of a U.S. aircraft carrier near the Korean Peninsula was... + más
About iurex | Privacy Policy | Disclaimer |